missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MIP-4 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Brand: Invitrogen PA578934
This item is not returnable.
View return policy
Description
Reconstitute with 0.2 mL of distilled water to yield a concentration of 500 μg/mL.
Macrophage Inflammatory Protein-4 (MIP-4), also called CCL18, is a chemokine expressed in the lymph nodes, lungs, placenta and bone marrow. Although the MIP-4s receptor remains undetermined, MIP-4 is known to act as a chemoattractant for activated and non-activated T cells.
Specifications
| MIP-4 | |
| Polyclonal | |
| Unconjugated | |
| CCL18 | |
| Alternative macrophage activation-associated CC chemokine 1; AMAC1; AMAC-1; CC chemokine ligand 18; CC chemokine PARC; C-C motif chemokine 18; C-C motif chemokine ligand 18; CCL18; CCL18(1-68); CCL18(3-69); CCL18(4-69); chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated); chemokine (C-C), dendritic; CKb7; CUL9; CUL-9; cullin 9; cullin-9; DCCK1; DC-CK1; dendritic cell chemokine 1; H7AP1; H-MIP-4; KIAA0708; Macrophage inflammatory protein 4; MIP4; MIP-4; p53-associated parkin-like cytoplasmic protein; PARC; parkin-like cytoplasmic p53 binding protein; pulmonary and activation-regulated chemokine; SCYA18; small inducible cytokine A18; small inducible cytokine subfamily A (Cys-Cys), member 18, pulmonary and activation-regulated; small-inducible cytokine A18; UbcH7-associated protein 1 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 6362 | |
| -20°C | |
| Lyophilized |
| ELISA, Western Blot | |
| 500 μg/mL | |
| PBS with 5MG BSA and 0.05MG sodium azide | |
| P55774 | |
| CCL18 | |
| E.coli-derived human CCL18 recombinant protein (Position: A21-A89). | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
MIP-4 Polyclonal Antibody, Invitrogen™ > 100 μg; Unconjugated
Spot an opportunity for improvement?Share a Content Correction
